Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[PERSONALIZED APPROACH TO LIPID-LOWERING THERAPY].

Revue medicale de Liege - 1 Jan 2000

Scheen A J, Descamps O S

Abstract excerpt

Individualized therapeutic strategy of dyslipidemias, classically relies upon a phenotypic approach. The pattern of lipid profile allows the choice of the best pharmacological option (statin, fibrate) and the patient's clinical risk profile allows the definition of therapeutic goals, especially LDL cholesterol target levels. Dyslipidemias have a major genetic component, which is best illustrated by familial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Individuality
Share to Precision Medicine
Share to Dyslipidemias

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hypolipidemic Agents

Share to Proprotein Convertase 9

Share to Proprotein Convertases

Share to Serine Endopeptidases

Source

Identifiers

PMID: 26285455

Genes

PCSK9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[PERSONALIZED APPROACH TO LIPID-LOWERING THERAPY].PMID 26285455Read ↗

Familial Hypercholesterolemia: Update and Review.Semantic proximity Read ↗

Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Semantic proximity Read ↗

Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial HypercholesterolemiaSemantic proximity Read ↗

Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes.Semantic proximity Read ↗

[Familial hypercholesterolemia - do we think enough about this severe disease?].Semantic proximity Read ↗

[Familial hypercholesterolemia].Semantic proximity Read ↗

[Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].Semantic proximity Read ↗

New Approaches in Detection and Treatment of Familial Hypercholesterolemia.Semantic proximity Read ↗

Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA).Semantic proximity Read ↗

[Familial hypercholesterolemia in the Czech Republic in 2016].Semantic proximity Read ↗

[Heterozygous familial hypercholesterolemia].Semantic proximity Read ↗

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.